<unk>  due to endogenous insulin can be congenital or acquired, apparent in the newborn period, or many years later. The<unk>  can be severe and life-threatening or a minor, occasional nuisance. By far the most common type of severe but transient<unk>  occurs accidentally in persons with type 1 diabetes who take insulin. *<unk>  due to endogenous insulin * Congenital hyperinsulinism * Transient neonatal hyperinsulinism (mechanism not known) * Focal hyperinsulinism (KATP channel disorders) * Paternal SUR1 mutation with clonal loss of heterozygosity of 11p15 * Paternal Kir6.2 mutation with clonal loss of heterozygosity of 11p15 * Diffuse hyperinsulinism * KATP channel disorders * SUR1 mutations * Kir6.2 mutations * Glucokinase gain-of-function mutations * Hyperammonemic hyperinsulinism (glutamate dehydrogenase gain-of-function mutations) * Short chain acyl coenzyme A dehydrogenase deficiency * Carbohydrate-deficient glycoprotein syndrome (Jaeken's Disease) * Beckwith-Wiedemann syndrome(suspected due to hyperinsulinism but pathophysiology uncertain: 11p15 mutation or IGF2 excess) * Acquired forms of hyperinsulinism * Insulinomas (insulin-secreting tumors) * Islet cell adenoma or adenomatosis * Islet cell carcinoma * Adult nesidioblastosis * Autoimmune insulin syndrome * Noninsulinoma pancreatogenous<unk>  * Reactive<unk>  (also see idiopathic postprandial syndrome) * Gastric dumping syndrome * Drug induced hyperinsulinism * Sulfonylurea * Aspirin * Pentamidine * Quinine * Disopyramide * Bordetella pertussis vaccine or infection * D-chiro-inositol and myo-inositol *<unk>  due to exogenous (injected) insulin * Insulin self-injected for treatment of diabetes (i.e., diabetic<unk>  * Insulin self-injected surreptitiously (e.g., Munchausen syndrome) * Insulin self-injected in a suicide attempt or fatality * Various forms of diagnostic challenge or "tolerance tests" * Insulin tolerance test for pituitary or adrenergic response assessment * Protein challenge * Leucine challenge * Tolbutamide challenge * Insulin potentiation therapy * Insulin-induced coma for depression treatment
Hyperinsulinemic hypoglycemia
Reactive hypoglycemia
Ketotic hypoglycemia
Diabetic hypoglycemia
Idiopathic hypoglycemia
Hyperproinsulinemia
Stress hyperglycemia
Ketosis-prone diabetes